Survival analysis studies using the Kaplan–Meier curve revealed that B-ALL patients who showed CD25+/CD123+ coexpression had shorter OS as compared to the negative ones (p < 0.01) (Figure 1). This evidence concerns the gene IL3RA and acute lymphoblastic leukemia.